[HTML] frontiersin.org

[HTML][HTML] Safety and pharmacokinetic profiles of long-acting injectable antiretroviral drugs for HIV-1 pre-exposure prophylaxis: A systematic review and meta-analysis of …

G Lazarus, VK Wangsaputra, Christianto… - Frontiers in …, 2021 - frontiersin.org
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …
被引用次数：17 相关文章
[HTML] nih.gov

[HTML][HTML] Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta …

G Lazarus, VK Wangsaputra, M Louisa… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …

Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of …

G Lazarus, VK Wangsaputra, M Louisa… - Frontiers in …, 2021 - scholar.ui.ac.id
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …

Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of …

G Lazarus, VK Wangsaputra, M Louisa… - Frontiers in …, 2021 - europepmc.org
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …

Safety and pharmacokinetic profiles of long-acting injectable antiretroviral drugs for HIV-1 pre-exposure prophylaxis: A systematic review and meta-analysis of …

G Lazarus, VK Wangsaputra, M Louisa… - Frontiers in …, 2021 - ora.ox.ac.uk
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …

Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of …

G Lazarus, VK Wangsaputra… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …
[PDF] academia.edu

[PDF][PDF] Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis …

G Lazarus, VK Wangsaputra, LM Christianto… - Front. Pharmacol. 12 …, 2021 - academia.edu
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …
[PDF] academia.edu

[PDF][PDF] Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis …

G Lazarus, VK Wangsaputra, LM Christianto… - Front. Pharmacol. 12 …, 2021 - academia.edu
Objectives: To investigate the safety and pharmacokinetic profiles of long-acting injectable
pre-exposure prophylaxis (LAI PrEP), notably cabotegravir (CAB-LA) and rilpivirine (RPV …